FII Holdings

BLISS GVS PHARMA LTD.

NSE : BLISSGVSBSE : 506197ISIN CODE : INE416D01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE112.65-1.5 (-1.31 %)
PREV CLOSE ( ) 114.15
OPEN PRICE ( ) 115.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 39688
TODAY'S LOW / HIGH ( )112.00 116.35
52 WK LOW / HIGH ( )69.15 148.95
NSE112.85-1.2 (-1.05 %)
PREV CLOSE( ) 114.05
OPEN PRICE ( ) 115.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 112.85 (5478)
VOLUME 367160
TODAY'S LOW / HIGH( ) 111.55 116.70
52 WK LOW / HIGH ( )69.2 149.6
upfii downfii 
Current Quarter
Prev Quarter
Company Quarter Ended 202312 % of Share Quarter Ended 202309 % of Share Changeupfii

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.